Structure of Elastase CAS 9004-06-2

Elastase CAS 9004-06-2

Identification

CAS Number

9004-06-2

Name

Elastase

Synonyms

9-Acridinamine, N-heptyl-1,2,3,4-tetrahydro-6-methoxy- [ACD/Index Name]
N-Heptyl-6-methoxy-1,2,3,4-tetrahydro-9-acridinamin [German] [ACD/IUPAC Name]
N-Heptyl-6-methoxy-1,2,3,4-tetrahydro-9-acridinamine [ACD/IUPAC Name]
N-Heptyl-6-méthoxy-1,2,3,4-tétrahydro-9-acridinamine [French] [ACD/IUPAC Name]
N-heptyl-6-methoxy-1,2,3,4-tetrahydroacridin-9-amine
1,2,3,4-Tetrahydro-N-heptyl-6-methoxy-9-acridinamine
187960-40-3 [RN]
9004-06-2 [RN]
9-Acridinamine, 1,2,3,4-tetrahydro-N-heptyl-6-methoxy-
9-Heptylamino-6-methoxy-1,2,3,4-tetrahydroacridine
Elastase
Heptyl-(6-methoxy-1,2,3,4-tetrahydro-acridin-9-yl)-amine
N-HEPTYL-3-METHOXY-5,6,7,8-TETRAHYDROACRIDIN-9-AMINE
Tacrine Analogue 21

SMILES

CCCCCCCNc1c2ccc(cc2nc3c1CCCC3)OC

StdInChI

InChI=1S/C21H30N2O/c1-3-4-5-6-9-14-22-21-17-10-7-8-11-19(17)23-20-15-16(24-2)12-13-18(20)21/h12-13,15H,3-11,14H2,1-2H3,(H,22,23)

StdInChIKey

JLHFZCNZUUJGRC-UHFFFAOYSA-N

Molecular Formula

C21H30N2O

Molecular Weight

326.476 

MDL Number

MFCD00130997

Properties

Appearance

Almost white or yellowish powder

Safety Data

RIDADR 

NONH for all modes of transport

WGK Germany

3

Specifications and Other Information of Our Elastase CAS 9004-06-2

Source

Porcine pancreas.

Process

Elastase is extracted from healthy porcine pancreas.

Test ItemsCP
CharactersAlmost white or yellowish powder
IdentificationConforms
Loss on drying≤ 8.0%(60℃ Dry in Vacuum, 4h)
Residue on ignition≤ 2.0%
Heavy metal≤ 25ppm
Activity≥ 30 unit/mg
Microbial Impurities
TAMC≤ 1000cfu/g
TYMC≤ 100cfu/g
E.coliConforms

Shelf Life

1 year

Storage

Store at -20℃ for long time.

Known Application

Elastase preparations are mainly used to improve abnormal lipid metabolism in serum and tissues, promote the dissimilation and excretion of cholesterol in the liver; increase the activity of lipase, promote neutral fat and lipoprotein, especially very low density lipoprotein and low density Lipoprotein metabolism, can inhibit the occurrence of atherosclerosis and inhibit experimental liver fibrosis and fat formation.

This product is developed by our R&D company Ulcho Biochemical Ltd (http://www.ulcho.com/).

This product is developed by our R&D company Watson International Ltd (https://www.watson-int.com/).